Metabolic Control of Smoldering Neuroinflammation.

immunometabolism macrophages metabolism microglia mitochondria progressive multiple sclerosis smoldering inflammation

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 06 05 2021
accepted: 31 05 2021
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 21 12 2021
Statut: epublish

Résumé

Compelling evidence exists that patients with chronic neurological conditions, which includes progressive multiple sclerosis, display pathological changes in neural metabolism and mitochondrial function. However, it is unknown if a similar degree of metabolic dysfunction occurs also in non-neural cells in the central nervous system. Specifically, it remains to be clarified (i) the full extent of metabolic changes in tissue-resident microglia and infiltrating macrophages after prolonged neuroinflammation (e.g., at the level of chronic active lesions), and (ii) whether these alterations underlie a unique pathogenic phenotype that is amenable for therapeutic targeting. Herein, we discuss how cell metabolism and mitochondrial function govern the function of chronic active microglia and macrophages brain infiltrates and identify new metabolic targets for therapeutic approaches aimed at reducing smoldering neuroinflammation.

Identifiants

pubmed: 34249016
doi: 10.3389/fimmu.2021.705920
pmc: PMC8262770
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

705920

Subventions

Organisme : Wellcome Trust
ID : RG G105713
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Peruzzotti-Jametti, Willis, Hamel, Krzak and Pluchino.

Déclaration de conflit d'intérêts

SP is co-founder, CSO, and shareholder (>5%) of CITC Ltd. and iSTEM Therapeutics and co-founder and Non-Executive Director at Asitia Therapeutics; LP-J is a shareholder of CITC Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Curr Med Chem. 2017;24(2):176-192
pubmed: 27881065
Nat Commun. 2014 May 12;5:3837
pubmed: 24815183
Nat Neurosci. 2019 Oct;22(10):1635-1648
pubmed: 31551592
Front Neurosci. 2020 Mar 31;14:213
pubmed: 32296300
Nat Rev Drug Discov. 2008 Jun;7(6):489-503
pubmed: 18511927
Nature. 2016 Dec 1;540(7631):139-143
pubmed: 27798601
Cell Rep. 2019 Jul 2;28(1):218-230.e7
pubmed: 31269442
BMC Immunol. 2015 May 12;16:28
pubmed: 25962726
Neuron. 2019 Jan 16;101(2):207-223.e10
pubmed: 30606613
Mol Cell. 2020 Jan 16;77(2):213-227.e5
pubmed: 31735641
Front Immunol. 2014 Sep 02;5:420
pubmed: 25228902
Development. 2014 Jan;141(1):5-9
pubmed: 24346695
Cancer Res. 2014 Jun 1;74(11):2986-98
pubmed: 24713431
Sci Rep. 2019 Aug 5;9(1):11313
pubmed: 31383928
J Neuroinflammation. 2018 Oct 10;15(1):284
pubmed: 30305119
Nat Rev Mol Cell Biol. 2019 Jul;20(7):436-450
pubmed: 30976106
Trends Immunol. 2015 Oct;36(10):569-577
pubmed: 26431936
J Neurochem. 2020 Apr;153(2):173-188
pubmed: 31742704
Cell. 2017 Jun 15;169(7):1276-1290.e17
pubmed: 28602351
Mol Immunol. 2015 Oct;67(2 Pt B):265-75
pubmed: 26105806
FASEB J. 2018 Jun 12;:fj201800285
pubmed: 29894669
J Clin Invest. 2016 Jul 1;126(7):2597-609
pubmed: 27270171
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Lancet. 2018 Mar 31;391(10127):1263-1273
pubmed: 29576505
Nat Cell Biol. 2018 Jul;20(7):745-754
pubmed: 29950572
Cancer Cell. 2005 Jan;7(1):77-85
pubmed: 15652751
Elife. 2016 Feb 19;5:
pubmed: 26894960
J Neuroimmunol. 2013 Mar 15;256(1-2):13-8
pubmed: 23290828
Glia. 2018 Feb;66(2):256-278
pubmed: 29058362
Immunity. 2018 Mar 20;48(3):599
pubmed: 29562204
Glia. 2018 Jun;66(6):1200-1212
pubmed: 29219210
Development. 2018 Oct 1;145(19):
pubmed: 30275240
Immunity. 2015 Mar 17;42(3):419-30
pubmed: 25786174
Trends Immunol. 2018 Jan;39(1):6-18
pubmed: 28923365
Cell. 2015 Mar 12;160(6):1061-71
pubmed: 25728668
Immunity. 2019 Jan 15;50(1):253-271.e6
pubmed: 30471926
Trends Mol Med. 2020 Oct;26(10):898-912
pubmed: 32448751
Nature. 2019 Apr;568(7751):E4
pubmed: 30918409
Neurobiol Dis. 2016 Jun;90:3-19
pubmed: 26494254
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Nat Immunol. 2016 Jul;17(7):797-805
pubmed: 27135602
Bioessays. 2013 Nov;35(11):965-73
pubmed: 24115022
J Neuroinflammation. 2014 Mar 26;11:58
pubmed: 24669778
Mov Disord. 2004 Jul;19(7):817-821
pubmed: 15254941
J Mol Neurosci. 2007 Sep;33(1):2-11
pubmed: 17901539
Nat Immunol. 2020 May;21(5):513-524
pubmed: 32284594
Semin Cell Dev Biol. 2021 Apr;112:137-144
pubmed: 32807643
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15803-8
pubmed: 18838687
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Glia. 2020 May;68(5):1031-1045
pubmed: 31793691
Front Immunol. 2020 Jan 10;10:2993
pubmed: 31998297
Glia. 2019 Oct;67(10):1859-1872
pubmed: 31231866
J Neurosci Res. 2014 Jun;92(6):723-31
pubmed: 24510633
Biochem J. 1986 Oct 1;239(1):121-5
pubmed: 3800971
Cells. 2019 Dec 18;9(1):
pubmed: 31861356
Nat Immunol. 2019 May;20(5):581-592
pubmed: 30962591
Immunity. 2017 Sep 19;47(3):566-581.e9
pubmed: 28930663
J Neuroimmunol. 2016 Mar 15;292:58-67
pubmed: 26943960
Nat Med. 2015 Mar;21(3):263-9
pubmed: 25686106
Sci Rep. 2017 Jul 10;7(1):4942
pubmed: 28694451
Mol Neurodegener. 2019 Jan 11;14(1):2
pubmed: 30634998
Front Immunol. 2018 Jul 12;9:1605
pubmed: 30050539
Prog Neurobiol. 2015 Apr;127-128:1-22
pubmed: 25802011
Epilepsia. 2015 Jul;56(7):e95-8
pubmed: 26011473
Cell. 2017 Aug 10;170(4):649-663.e13
pubmed: 28802038
J Exp Med. 2016 Aug 22;213(9):1655-62
pubmed: 27481132
Nat Commun. 2020 Mar 25;11(1):1559
pubmed: 32214088
EMBO Rep. 2007 Oct;8(10):912-3
pubmed: 17906671
Brain. 2010 Oct;133(10):2983-98
pubmed: 20855416
Nat Rev Neurosci. 2007 Jan;8(1):57-69
pubmed: 17180163
Exp Cell Res. 2019 Apr 15;377(1-2):10-16
pubmed: 30817930
Am J Physiol. 1990 Mar;258(3 Pt 1):C377-89
pubmed: 2138418
Science. 2018 Feb 9;359(6376):684-688
pubmed: 29301957
Nat Commun. 2020 Dec 8;11(1):6296
pubmed: 33293558
Nat Neurosci. 2016 Aug;19(8):995-8
pubmed: 27294511
J Clin Invest. 2015 Apr;125(4):1379-87
pubmed: 25831442
Biochem J. 2011 Sep 15;438(3):433-6
pubmed: 21787310
Front Physiol. 2017 Jun 27;8:428
pubmed: 28701960
FEBS Lett. 2013 Mar 18;587(6):756-62
pubmed: 23395614
Trends Mol Med. 2018 Oct;24(10):838-855
pubmed: 30100517
Cell. 2021 Feb 18;184(4):1000-1016.e27
pubmed: 33508229
Science. 2010 Nov 5;330(6005):841-5
pubmed: 20966214
Metab Brain Dis. 2015 Feb;30(1):233-9
pubmed: 25037166
Diabetologia. 2017 Jul;60(7):1304-1313
pubmed: 28382382
J Nucl Med. 2010 Apr;51(4):596-609
pubmed: 20351351
Science. 2019 Jan 25;363(6425):
pubmed: 30679343
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1958;196(6):611-26
pubmed: 13534602
Annu Rev Cell Dev Biol. 2014;30:357-91
pubmed: 25288115
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2012-2017
pubmed: 28167760
Dev Cell. 2021 May 3;56(9):1221-1233
pubmed: 33887204
Glia. 2021 Mar;69(3):567-578
pubmed: 32946147
Neuroscience. 2021 Jan 15;453:301-311
pubmed: 33212223
Biochim Biophys Acta. 2013 Nov-Dec;1827(11-12):1320-31
pubmed: 23269318
Brain. 2012 Mar;135(Pt 3):886-99
pubmed: 22366799
Mol Neurobiol. 2018 Mar;55(3):2320-2332
pubmed: 28343295
Neuron. 2020 Mar 4;105(5):837-854.e9
pubmed: 31902528
Brain. 2019 Sep 1;142(9):2787-2799
pubmed: 31497864
Brain. 2017 Jul 1;140(7):1900-1913
pubmed: 28541408
Curr Biol. 2009 Dec 1;19(22):R1046-52
pubmed: 19948145
Semin Immunol. 2015 Aug;27(4):286-96
pubmed: 26360589
Elife. 2019 May 07;8:
pubmed: 31063129
J Neuroinflammation. 2019 Mar 13;16(1):61
pubmed: 30866963
Biochem J. 2009 Jan 1;417(1):1-13
pubmed: 19061483
Front Mol Neurosci. 2017 Jun 30;10:206
pubmed: 28713239
J Cell Biol. 2016 Feb 15;212(4):379-87
pubmed: 26858267
Nat Immunol. 2008 Nov;9(11):1261-9
pubmed: 18820681
Am J Physiol Lung Cell Mol Physiol. 2009 Apr;296(4):L624-34
pubmed: 19168575
Trends Neurosci. 2013 Oct;36(10):587-97
pubmed: 23968694
Cell. 1998 Apr 17;93(2):229-40
pubmed: 9568715
Free Radic Biol Med. 2006 Jul 1;41(1):56-64
pubmed: 16781453
Trends Immunol. 2017 Jun;38(6):395-406
pubmed: 28396078
Cell Metab. 2016 Jul 12;24(1):158-66
pubmed: 27374498
Sci Rep. 2019 Aug 20;9(1):12106
pubmed: 31431671
J Biol Chem. 2003 Mar 7;278(10):8516-25
pubmed: 12496265
Int J Mol Sci. 2020 Aug 19;21(17):
pubmed: 32825027
Annu Rev Immunol. 2017 Apr 26;35:441-468
pubmed: 28226226
Front Mol Neurosci. 2018 Mar 15;11:57
pubmed: 29599706
Nature. 2018 Apr;556(7702):501-504
pubmed: 29670287
Diabetologia. 2014 May;57(5):1067-77
pubmed: 24488024
Nat Immunol. 2014 Apr;15(4):323-32
pubmed: 24562310
Glia. 2007 Sep;55(12):1263-71
pubmed: 17659525
Neuron Glia Biol. 2010 Nov;6(4):263-76
pubmed: 22018046
Nat Immunol. 2019 Apr;20(4):420-432
pubmed: 30858618
Mediators Inflamm. 2017;2017:9029327
pubmed: 29386753
J Neuroinflammation. 2020 Jan 11;17(1):18
pubmed: 31926553
JAMA. 2019 Jan 15;321(2):175-187
pubmed: 30644981
Nature. 2016 Jul 27;535(7613):551-5
pubmed: 27466127
Br J Exp Pathol. 1970 Feb;51(1):97-105
pubmed: 5434449
Swiss Med Wkly. 2016 Nov 10;146:w14374
pubmed: 27878792
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):295-302
pubmed: 33184094
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7820-5
pubmed: 23610393
Prog Neurobiol. 2020 Jan;184:101719
pubmed: 31704314
Neurol Neuroimmunol Neuroinflamm. 2018 Mar 06;5(3):e443
pubmed: 29520366
Science. 2016 Aug 19;353(6301):aad8670
pubmed: 27338705
J Exp Med. 2020 May 4;217(5):
pubmed: 32097464
Am J Pathol. 2002 Jan;160(1):101-12
pubmed: 11786404
Cell Metab. 2020 Feb 4;31(2):422-437.e5
pubmed: 31883840
Trends Immunol. 2021 Jan;42(1):45-58
pubmed: 33279412
Front Physiol. 2020 Apr 28;11:393
pubmed: 32411016
J Clin Invest. 2015 May;125(5):2161-70
pubmed: 25893602
J Neural Transm Suppl. 1995;46:139-47
pubmed: 8821049
Cell Rep. 2020 Feb 4;30(5):1271-1281
pubmed: 32023447
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
Nat Immunol. 2016 Sep;17(9):1037-1045
pubmed: 27348412
Cell Stem Cell. 2018 Mar 1;22(3):355-368.e13
pubmed: 29478844
Cell Rep. 2016 Oct 11;17(3):684-696
pubmed: 27732846
PLoS Biol. 2021 Apr 7;19(4):e3001166
pubmed: 33826607
Biochim Biophys Acta Bioenerg. 2018 Mar;1859(3):201-214
pubmed: 29273412
Bioessays. 2010 Nov;32(11):958-66
pubmed: 20824657
Trends Mol Med. 2004 Nov;10(11):549-57
pubmed: 15519281
N Engl J Med. 2017 Jan 19;376(3):209-220
pubmed: 28002688
Nat Commun. 2021 Jan 29;12(1):707
pubmed: 33514727
Nat Rev Drug Discov. 2019 Dec;18(12):905-922
pubmed: 31399729
J Immunol. 2009 Jun 15;182(12):8005-14
pubmed: 19494326
J Biol Chem. 2015 Oct 23;290(43):26043-50
pubmed: 26374899
Brain Behav Immun. 2018 Feb;68:183-196
pubmed: 29061364
Mult Scler Int. 2015;2015:681289
pubmed: 26839705
Brain Behav Immun. 2020 Jul;87:413-428
pubmed: 31978523
Cell Metab. 2014 Sep 2;20(3):483-98
pubmed: 25130399
Glia. 2019 Jun;67(6):1047-1061
pubmed: 30637805
ACS Chem Neurosci. 2018 May 16;9(5):901-905
pubmed: 29370524
PLoS One. 2013 Aug 20;8(8):e72046
pubmed: 23977201
J Neuroinflammation. 2020 Jul 27;17(1):224
pubmed: 32718316
Nature. 2019 Feb;566(7744):388-392
pubmed: 30760929
FEBS Lett. 2010 Apr 16;584(8):1437-42
pubmed: 20227410
Biochim Biophys Acta. 2016 Nov;1861(11):1796-1807
pubmed: 27614008
Cell Stem Cell. 2019 Oct 3;25(4):473-485.e8
pubmed: 31585093
J Mol Neurosci. 2010 Oct;42(2):145-53
pubmed: 20333481
J Neurochem. 2018 Jan;144(2):186-200
pubmed: 29205357
Alzheimers Dement (N Y). 2017 Dec 06;4:28-36
pubmed: 29955649
PLoS One. 2016 Feb 12;11(2):e0149050
pubmed: 26872335
Cell. 2012 Mar 16;148(6):1132-44
pubmed: 22424225
JAMA Neurol. 2019 Dec 1;76(12):1474-1483
pubmed: 31403674
Sci Rep. 2019 May 17;9(1):7508
pubmed: 31101881
Ann Neurol. 2015 Nov;78(5):710-21
pubmed: 26239536
J Cell Biol. 2014 Mar 17;204(6):919-29
pubmed: 24616225
Cell. 2016 Oct 6;167(2):457-470.e13
pubmed: 27667687
Glia. 1997 Sep;21(1):2-21
pubmed: 9298843
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Cell. 2013 Sep 26;155(1):160-71
pubmed: 24055366
Cell Metab. 2017 Jan 10;25(1):128-139
pubmed: 27720676
Am J Pathol. 2013 Aug;183(2):526-41
pubmed: 23759513

Auteurs

Luca Peruzzotti-Jametti (L)

Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Cory M Willis (CM)

Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Regan Hamel (R)

Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Grzegorz Krzak (G)

Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Stefano Pluchino (S)

Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH